The City of Hamilton has parted ways with top planning boss Arvin Prasad amid a probe of misconduct allegations linked to his former job in Markham. Hamilton announced in a statement late Monday that ...

Prasad’s tenure at the helm of CBER was marked by a tumultuous relationship with the biopharma industry. (iStock / Getty Images Plus) As the calendar turned from April to May, a big change came to the ...

Prasad Kalyanaraman, VP of AWS Infrastructure Services, has been named to Amazon’s senior leadership team. (Amazon Photo) Amazon added a new member to its senior leadership team Wednesday, naming AWS ...

OAK PARK, Ill. (WLS) -- The abrupt closure of West Suburban Medical Center in Oak Park last month came as a shock to suddenly unemployed staff, a wide variety of patients, and the communities relying ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

Vinay Prasad, M.D., is out again as the chief medical and scientific officer for the U.S. Food and Drug Administration (FDA). Last July, Prasad tendered his resignation in the wake of a fiery attack ...

The revolving door at the Food and Drug Administration has pushed out another top official: Vinay Prasad, the controversial head of the agency’s vaccine and gene therapy arm, will depart in April.

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he's departed after controversial decisions ...

Homeland Security Secretary Kristi Noem is out, as Donald Trump names Markwayne Mullin to replace her. Will the DHS personnel change also affect ICE policy? Plus, does the U.S. have enough air-defense ...

The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said Friday. Limited time: Save 25% on NBC News subscription Get exclusive ...

Successor to be named before Prasad's departure Prasad had received criticism for his division's handling of rare disease treatments Prasad to return to UCSF March 6 (Reuters) - The controversial head ...

Vinay Prasad's signature appeared on a letter telling Moderna that the agency was refusing to review the biotech’s application for a new mRNA-based flu vaccine, a decision that was later reversed.